Curanail 5% w/v Medicated Nail Lacquer
- Name:
Curanail 5% w/v Medicated Nail Lacquer
- Company:
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 20/04/20
(Click to Download) Summary of Product Characteristics last updated on medicines.ie: 9/2/2020
Click on this link to Download PDF directly
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
 Ltd.jpg)
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Acnecide Gel 5% | Active Ingredients Benzoyl Peroxide, hydrous |
| Medicine Name Azzalure | Active Ingredients Botulinum Toxin Type A |
| Medicine Name Curanail 5% w/v Medicated Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Differin Cream 0.1% w/w | Active Ingredients Adapalene |
| Medicine Name Differin Gel | Active Ingredients Adapalene |
| Medicine Name Efracea capsules | Active Ingredients Doxycycline monohydrate |
| Medicine Name Epiduo 0.1%/2.5% Gel | Active Ingredients Adapalene, Benzoyl Peroxide |
| Medicine Name Etrivex 500 micrograms/g Shampoo | Active Ingredients Clobetasol Propionate |
| Medicine Name Loceryl Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
| Medicine Name Metvix Cream | Active Ingredients Methyl Aminolevulinate Hydrochloride |
| Medicine Name Mirvaso 3mg/g Gel | Active Ingredients brimonidine tartrate |
| Medicine Name Rozex Cream | Active Ingredients Metronidazole |
| Medicine Name Rozex Gel | Active Ingredients Metronidazole |
| Medicine Name Silkis Ointment | Active Ingredients Calcitriol |
| Medicine Name Soolantra 10 mg/g Cream | Active Ingredients Ivermectin |
| Medicine Name Tetralysal 300 Capsules | Active Ingredients Lymecycline |
Items Per Page :
1 - 0 of 16 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 20 April 2020 PIL
Reasons for updating
- Change to marketing authorisation holder
Updated on 9 February 2020
Reasons for updating
- Improved presentation of SmPC
Updated on 13 June 2019
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Updated on 29 June 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 6 June 2018
Updated on 5 June 2018
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Updated on 9 May 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 2 February 2018 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
- Section 4.4: addition of the following: 'A systemic or local allergic reaction could possibly occur after use of this product. If this happens, the product should be stopped immediately and medical advice should be sought. Remove the product carefully by using a nail remover solution. The product should not be reapplied.'
- Section 4.8: Change in the following: 'Adverse drug reactions
arewere rare in clinical trials.' Also, slight changes to the wording of text in the table. - Section 6.5: Addition of '2.5ml-glass bottle with accessories (30 nail files, 30 cleaning swabs, 30 applicators).
- Section 10: Change in the date of revision to 'December 2017'.
Updated on 2 February 2018
Reasons for updating
- New SmPC for new product
Legal category: Supply through pharmacy only
Updated on 14 October 2016 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Addition of new applicator cap
Updated on 11 October 2016 PIL
Reasons for updating
- New PIL for new product
Updated on 11 October 2016 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to date of revision
Updated on 25 July 2016 PIL
Reasons for updating
- Introduction of new pack/pack size
Updated on 25 July 2016 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Addition of a 1.25ml pack size.
Updated on 7 September 2015 PIL
Reasons for updating
- Change to packaging
Updated on 13 April 2015 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Renewal of the Marketing authorization and variation to update section 6.3 of the SPC and section 5 of the PIL as the in-use stability data provided allows proposing a Shelf life after first opening of 6 months
Updated on 2 April 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to information about pregnancy or lactation
- Change to date of revision
Updated on 30 April 2014 PIL
Reasons for updating
- Change to side-effects
- Change to information about pregnancy or lactation
Updated on 28 April 2014 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Information on how to report adverse events has been added to section 4.8
The SPC has been updated in line with the QRD.
Warning regarding the use of organic solvents has been added to section 4.4
The SPC has been updated in line with the QRD.
Warning regarding the use of organic solvents has been added to section 4.4
Updated on 19 November 2013 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 5.3 - Preclinical safety data
- Change to improve clarity and readability
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 3, information on the appearance of the nail lacquer has been added.
Some additional information has been added to section 5.3.
The overall readability of the SPC has also been improved.
Some additional information has been added to section 5.3.
The overall readability of the SPC has also been improved.
Updated on 18 November 2013 PIL
Reasons for updating
- Correction of spelling/typing errors
- Improved electronic presentation
Updated on 30 April 2012 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
None provided
Updated on 27 April 2012 PIL
Reasons for updating
- New PIL for new product